DocCheck FY26 H1 EBIT drops to EUR 2.7 million-EUR 2.9 million; revenue rises to EUR 27.7 million-EUR 28 million
Reuters2026/08/05 15:52- DocCheck released preliminary H1 2026 results, with revenue rising to EUR 27.7-28.0 million from EUR 26.5 million a year earlier.
- EBIT fell to EUR 2.7-2.9 million from EUR 3.9 million in the prior-year period.
- Cash and cash equivalents dropped to EUR 11.9 million from EUR 15.4 million, partly due to ongoing real-estate projects.
- DocCheck gave no guidance yet on earnings per share for the period.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
No Public Money Behind El Salvador’s New Bitcoin, IMF Confirms
PetroTal forecasts FY2026 adjusted EBITDA at USD 110 million-120 million
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
